灰飞虱Bursicon基因的克隆、序列分析及在不同发育阶段的表达

Bursicon是通过G蛋白受体调节昆虫表皮硬化及展翅的功能蛋白, 它在昆虫蜕皮后的表皮硬化过程中起着关键作用。为探讨灰飞虱Laodelphax striatellus的 bursicon的功能, 利用RT-PCR和RACE技术克隆获得1 126 bp的bursicon α和761 bp的bursicon β全长序列, 将其分别命名为Lsburs-α和Lsburs-β。生物信息学分析表明： Lsburs-α开放阅读框长483 bp, 编码160个氨基酸, 该蛋白具有2个N-豆蔻酰化位点、 3个酪蛋白激酶Ⅱ磷酸化位点以及2个蛋白激酶C磷酸化位点。Lsburs-β开放阅读框长417 bp, 编码138个氨基酸, 该蛋白具有2个N-豆蔻酰化位点、 3个酪蛋白激酶Ⅱ磷酸化位点以及1个酪氨酸激酶磷酸化位点。qRT-PCR结果表明： Lsburs-α和Lsburs-β在灰飞虱各龄期均有转录表达, 并在若虫期随龄期增加呈上升趋势, 在羽化期达到峰值, 成虫期表达量逐渐降低。结果提示bursicon与灰飞虱蜕皮后的外表皮硬化关系密切。本文结果为深入研究bursicon的功能、受体调节和信号通路等奠定了基础。     

土体干缩裂缝研究进展

土体干缩裂缝的形成和发展是一个复杂的物理过程,会对土体的强度、稳定性和渗透性等产生影响,其影响范围广泛分布于土壤学、农业、工程地质和环境保护等学科.本文在明确土体干缩裂缝研究重要性的基础上,通过收集整理国内外有关土体干缩裂缝研究的既有文献资料,综述了土体干缩裂缝的理论研究、实用性研究以及裂缝形态定量分析研究,分析和讨论了土体干缩裂缝在研究领域、研究内容和研究方法方面的不足之处,并指出土体干缩裂缝的未来发展方向.     

棉铃虫齿唇姬蜂嗅觉受体基因 CchlOrco 的克隆及组织表达谱分析

【目的】昆虫的嗅觉受体（olfactory receptors, ORs）一般以气味分子特异的ORs与共受体（ co-Receptor, Orco）通过形成异质二聚体在嗅觉感受中发挥关键作用,其中Orco由于具有序列的保守性而受到广泛的重视。本研究旨在克隆棉铃虫齿唇姬蜂 Campoletis chlorideae 的Orco基因,并对其组织表达谱进行分析。【方法】利用RT-PCR技术和转录组分析技术克隆棉铃虫齿唇姬蜂的Orco基因,并对其编码的氨基酸序列进行生物信息学分析;利用Real-time PCR技术对该基因在该蜂成虫不同组织中的表达量进行分析。【结果】获得了棉铃虫齿唇姬蜂 Orco 的全长cDNA序列,命名为 CchlOrco（GenBank登录号：KP255444）。序列分析表明, 该基因开放阅读框全长1 437 bp,编码478个氨基酸,预测该氨基酸序列具有7个跨膜区。CchlOrco 主要在成虫触角中表达,且在雄蜂触角中的表达量最高,是雌蜂触角中表达量的8.0倍,而在其他组织中表达量极低。【结论】本研究克隆了棉铃虫齿唇姬蜂 CchlOrco 序列全长,明确了其在成虫不同组织中的表达水平,为进一步研究该基因及其他嗅觉受体基因功能奠定了基础。     

荒漠昆虫小胸鳖甲Ras GTP酶激活蛋白基因 MpRasGAP 的克隆及低温表达分析

【目的】丝裂原活化蛋白激酶 (mitogen activated protein kinase, MAPK)级联是细胞的重要信息传递系统之一,Ras GTP酶激活蛋白（Ras GTPase-activating protein, RasGAP）基因 RasGAP 和c-Jun氨基末端激酶（c-Jun N-terminal kinase, JNK）基因 JNK 分别是MAPK信号转导途径的上、下游基因。本研究旨在确定荒漠昆虫小胸鳖甲 Microdera punctipennis RasGAP 及 JNK 基因对低温的响应情况。【方法】从荒漠甲虫小胸鳖甲中克隆获得 RasGAP 基因的cDNA序列,利用生物信息学分析软件分析其氨基酸序列并构建进化树,利用实时荧光定量PCR检测低温胁迫条件下 RasGAP 和 JNK 基因的表达情况。【结果】小胸鳖甲RasGAP cDNA的开放阅读框2 523 bp,命名为 MpRasGAP （GenBank登录号：KM677930）,编码840个氨基酸,分子量96.594 kDa,编码蛋白MpRasGAP属于RasGAP超家族。MpRasGAP与赤拟谷盗 Tribolium castaneum RasGAP的氨基酸序列一致性达89%。小胸鳖甲在4℃和-4℃低温胁迫1 h后,MpRasGAP 的mRNA水平都显著高于室温对照（25℃）。小胸鳖甲在4℃处理3 h或-4℃处理1 h后, MpJNK 的mRNA水平也显著升高。【结论】本研究结果表明小胸鳖甲MpRasGAP 和 MpJNK 的mRNA水平受低温诱导。研究结果有助于深入研究荒漠昆虫在低温下MAPK信号转导途径的作用机制。     

Ecotoxicity evaluation of PFBSK for the whole environmental compartments and comprehensive comparison of hazard and risk to PFOS

A series of perfluorobutane sulfonate (PFBS)-related substances are produced as the alternatives to corresponding perfluorooctane sulfonate (PFOS). However, there is little reliable information about PFBS available for the whole ecotoxicology compartments. At present, its ecotoxicity of perfluorobutane sulfonate potassium (PFBSK) was selected as a typical PFBS chemical to investigate and evaluate its aquatic, terrestrial, microorganism and sediment toxicity according to the Organization for Economic Cooperation and Development (OECD) guideline under the framework of the REACH regulation. Meanwhile, the ecotoxicology hazard and risk for PFBSK and PFOS were compared comprehensively.

PFBSK did not show acute and chronic aquatic, microorganisms and terrestrial animal toxicity, while exhibited some terrestrial plants toxicity. The ecotoxicology of PFBSK decreased sharply except for terrestrial plants compared with PFOS. Especially, for acute and chronic aquatic ecotoxicity, PFBSK is lower than 100 times those of PFOS.

Although the similar terrestrial plants toxicity level was observed for PFBSK and PFOS, the lower risk of PFBSK was deduced for the reason that there was far less chances to be exposed and retained in the soil and sediment for its high water solubility and low adsorption.

In conclusion, PFBSK showed lower ecotoxicity hazard and risk than those of PFOS. PFBSK could be an environmental friendly alternative to PFOS.     

Insight into the structural requirements of thiophene-3-carbonitriles-based MurF inhibitors by 3D-QSAR,molecular docking and molecular dynamics study

The discovery of clinically relevant inhibitors against MurF enzyme has proven to be a challenging task. In order to get further insight into the structural features required for the MurF inhibitory activity, we performed pharmacophore and atom-based three-dimensional quantitative structure–activity relationship studies for novel thiophene-3-carbonitriles based MurF inhibitors. The five-feature pharmacophore model was generated using 48 inhibitors having IC₅₀ values ranging from 0.18 to 663?μm. The best-fitted model showed a higher coefficient of determination (R²?=?0.978), cross-validation coefficient (Q²?=?0.8835) and Pearson coefficient (0.9406) at four component partial least-squares factor. The model was validated with external data set and enrichment study. The effectiveness of the docking protocol was validated by docking the co-crystallized ligand into the catalytic pocket of MurF enzyme. Further, binding free energy calculated by the molecular mechanics generalized Born surface area approach showed that van der Waals and non-polar solvation energy terms are the main contributors to ligand binding in the active site of MurF enzyme. A 10-ns molecular dynamic simulation was performed to confirm the stability of the 3ZM6-ligand complex. Four new molecules are also designed as potent MurF inhibitors. These results provide insights regarding the development of novel MurF inhibitors with better binding affinity.     

翘嘴鳜per1 mRNA表达量分析中采用的内参基因稳定性比较

为筛选生物钟核心基因per1表达定量中的相对稳定性最好的内参基因,本研究取翘嘴鳜成鱼心脏、肝脏、肾脏、脑、红肌、白肌、肠、眼和脾等九个组织为研究对象,选取GAPDH、18S rRNA、β-actin、rps29、RPL13a、B2M和EF1a为内参基因,采用实时荧光定量PCR(qRT-PCR)对per1基因mRNA表达水平进行检测分析。研究结果表明18S rRNA和GAPDH的平均稳定值M最低,相对表达量最稳定。以18S rRNA和GAPDH为内参基因时分析发现per1基因表达量在肝脏中最高。本研究为在鱼类per1 mRNA表达检测过程中选用稳定的内参基因提供了实验和理论参考。     

Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead

Introduction: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide. However, there remain many unmet clinical needs, from diagnosis to treatment strategies. The inherent complexity of the molecular characteristics of PDAC has made it difficult to meet these challenges, rendering proteomic profiling of PDAC a critical area of research.

Area covered: In this review, we present recent advances in mass spectrometry (MS) and its current application in proteomic studies on PDAC. In addition, we discuss future directions for research that can efficiently incorporate current MS-based technologies that address key issues of PDAC proteomics.

Expert commentary: Compared with other cancer studies, little progress has been made in PDAC proteomics, perhaps attributed to the difficulty in performing in-depth and large-scale clinical studies on PDAC. However, recent advances in mass spectrometry can advance PDAC proteomics past the fundamental research stage.